TransMedics reiterates 2026 revenue guidance of $727M-$757M while targeting CHOPS IDE implementation in early Q3 2026
TransMedics Group, Inc. Common Stock · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · Now $67.53
-13% in 7d after detection
Post-detection moves
1h
—
1d
-0.0%
3d
-12%
7d
-13%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS